ArticleSN comprehensive clinical medicine2021

Tocilizumab, Remdesivir, Favipiravir, and Dexamethasone Repurposed for COVID-19: a Comprehensive Clinical and Pharmacovigilant Reassessment.

Mina T KelleniPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.